Key Product Details

Species Reactivity

Validated:

Human

Cited:

Human

Applications

Validated:

Immunohistochemistry, Western Blot, Neutralization, Immunocytochemistry, Simple Western

Cited:

Western Blot, Neutralization, Immunocytochemistry, Bioassay

Label

Unconjugated

Antibody Source

Polyclonal Sheep IgG
Loading...

Product Specifications

Immunogen

Chinese hamster ovary cell line CHO-derived recombinant human Laminin alpha 4
Gln826-Ala1816, predicted
Accession # EAW48267

Specificity

Detects human Laminin alpha 4 in direct ELISAs and Western blots. In direct ELISAs, approximately 15% cross-reactivity with recombinant mouse Laminin alpha 4 is observed.

Clonality

Polyclonal

Host

Sheep

Isotype

IgG

Endotoxin Level

<0.10 EU per 1 μg of the antibody by the LAL method.

Scientific Data Images for Human Laminin  alpha 4 Antibody

Detection of Human Laminin a4 antibody by Western Blot.

Detection of Human Laminin alpha 4 by Western Blot.

Western blot shows lysates of human placenta tissue. PVDF membrane was probed with 2 µg/mL of Sheep Anti-Human Laminin a4 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF7340) followed by HRP-conjugated Anti-Sheep IgG Secondary Antibody (Catalog # HAF016). A specific band was detected for Laminin a4 at approximately 200-220 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.

Laminin a4 antibody in T98G Human Cell Line by Immunocytochemistry (ICC).

Laminin alpha 4 in T98G Human Cell Line.

Laminin a4 was detected in immersion fixed T98G human glioblastoma cell line, induced (upper panel) or not (lower panel) with StemXVivo EMT Inducing Media Supplement (Catalog # CCM017), using Sheep Anti-Human Laminin a4 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF7340) at 10 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Sheep IgG Secondary Antibody (red; Catalog # NL010) and counterstained with DAPI (blue). Specific staining was localized to cytoplasm and cell surfaces. View our protocol for Fluorescent ICC Staining of Cells on Coverslips.

Laminin a4 antibody in Human Placenta by Immunohistochemistry (IHC-P).

Laminin alpha 4 in Human Placenta.

Laminin a4 was detected in immersion fixed paraffin-embedded sections of human placenta using Sheep Anti-Human Laminin a4 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF7340) at 3 µg/mL for 1 hour at room temperature followed by incubation with the Anti-Sheep IgG VisUCyte™ HRP Polymer Antibody (Catalog # VC006). Before incubation with the primary antibody, tissue was subjected to heat-induced epitope retrieval using Antigen Retrieval Reagent-Basic (Catalog # CTS013). Tissue was stained using DAB (brown) and counterstained with hematoxylin (blue). Specific staining was localized to Golgi apparatus. View our protocol for IHC Staining with VisUCyte HRP Polymer Detection Reagents.

Detection of Human Laminin a4 antibody by Simple WesternTM.

Detection of Human Laminin alpha 4 by Simple WesternTM.

Simple Western lane view shows lysates of human placenta tissue, loaded at 0.2 mg/mL. A specific band was detected for Laminin a4 at approximately 233 kDa (as indicated) using 20 µg/mL of Sheep Anti-Human Laminin a4 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF7340) followed by 1:50 dilution of HRP-conjugated Anti-Sheep IgG Secondary Antibody (Catalog # HAF016). This experiment was conducted under reducing conditions and using the 66-440 kDa separation system.

Adhesion Induced by Laminin  alpha 4 and Neutralization by Human Laminin  alpha 4 Antibody.

Adhesion Induced by Laminin alpha 4 and Neutralization by Human Laminin alpha 4 Antibody.

Recombinant Human Laminin a4 (Catalog # 7340-A4) supports adhesion in the HT1080 human fibrosarcoma cell line in a dose-dependent manner (orange line), as measured by Calcein AM. Adhesion elicited by Recombinant Human Laminin a4 (5 µg/mL) is neutralized (green line) by increasing concentrations of Sheep Anti-Human Laminin a4 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF7340). The ND50 is typically 1.5-7.5 µg/mL.

Detection of Human Laminin alpha 4 by Western Blot

Detection of Human Laminin alpha 4 by Western Blot

Flow induces remodeling of the endothelial extracellular matrix.A, Proteome and (B) cell surface proteome data of identified laminins. T or CT represents the enzyme used for protein digestion. The depicted numbers represent the biotin-modified lysine residue. C, Schematic representation of laminin 411 with the linker region between domains LG3 and LG4. The blue lysine residues were found to be decreased under flow conditions (as depicted in panel B). D, Immunoblot analysis of LAMA4 in ECs exposed to flow over time. alpha -tubulin was used as a loading control. E, Protein distribution of LAMA5 and LAMA4 after flow-exposure. Green represents LAMA4 or LAMA5, blue is HOECHST. The scale bar is 10 μm. Depicted are maximum intensity projections. F, Proteome and (G) cell surface proteome data of identified fibulins. H, Immunofluorescence analysis of EFEMP1 and FBLN2 abundance and distribution affected by flow. Red is VE-cadherin, blue is HOECHST. Depicted are maximum intensity projections. Micrographs are representative for 3 independent experiments. The scale bar is 10 μm. Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/32332107), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Laminin alpha 4 by Western Blot

Detection of Laminin alpha 4 by Western Blot

Knockdown of LAMA4 suppresses the malignant behaviour of osteosarcoma and accelerates ER stress-induced apoptosis. A The expression levels of LAMA4 in osteosarcoma (n = 88) and normal tissues (n = 564) were analysed from the TNMplot database. B LAMA4 was knocked down in MNNG/HOS and 143B cells. The expression of LAMA4 was detected by Western blot. GAPDH was used as the loading control. C-D The cells (3000 cells/well) with or without LAMA4 depletion were tested for cell growth in the colony formation assay. Viable colonies after 1 week were counted and are shown (C). Data are depicted as bar graphs (D). E-F The migration of the indicated cells was detected by Transwell assays. Representative images of crystal violet-stained culture plates are shown (E). Data are depicted as bar graphs (F). G-H MNNG/HOS cells with or without LAMA4 knockdown were treated with 3 μM TM for 36 h. Cell apoptosis and cell viability were analysed by Western blot (G) and CCK8 assays (H). GAPDH was used as the loading control. I-J MNNG/HOS cells with or without LAMA4 knockdown were treated with 1 μM TG for 36 h. Cell apoptosis and cell viability were analysed by Western blot (I) and CCK8 assays (J). GAPDH was used as the loading control. K-M MNNG/HOS cells (106 cells per mouse) with or without LAMA4 knockdown were injected subcutaneously into nude mice (n = 4). Representative images of xenograft tumours (K). The weights of the tumours were calculated and analysed (L). The expression levels of PARP, cleaved PARP and LAMA4 in tumours were measured by Western blot (M). Data in D, F, H, J, L were analysed by Student’s t test, *p < 0.05, **p < 0.01, ***p < 0.001 Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36539799), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Laminin alpha 4 by Western Blot

Detection of Laminin alpha 4 by Western Blot

Knockdown of LAMA4 suppresses the malignant behaviour of osteosarcoma and accelerates ER stress-induced apoptosis. A The expression levels of LAMA4 in osteosarcoma (n = 88) and normal tissues (n = 564) were analysed from the TNMplot database. B LAMA4 was knocked down in MNNG/HOS and 143B cells. The expression of LAMA4 was detected by Western blot. GAPDH was used as the loading control. C-D The cells (3000 cells/well) with or without LAMA4 depletion were tested for cell growth in the colony formation assay. Viable colonies after 1 week were counted and are shown (C). Data are depicted as bar graphs (D). E-F The migration of the indicated cells was detected by Transwell assays. Representative images of crystal violet-stained culture plates are shown (E). Data are depicted as bar graphs (F). G-H MNNG/HOS cells with or without LAMA4 knockdown were treated with 3 μM TM for 36 h. Cell apoptosis and cell viability were analysed by Western blot (G) and CCK8 assays (H). GAPDH was used as the loading control. I-J MNNG/HOS cells with or without LAMA4 knockdown were treated with 1 μM TG for 36 h. Cell apoptosis and cell viability were analysed by Western blot (I) and CCK8 assays (J). GAPDH was used as the loading control. K-M MNNG/HOS cells (106 cells per mouse) with or without LAMA4 knockdown were injected subcutaneously into nude mice (n = 4). Representative images of xenograft tumours (K). The weights of the tumours were calculated and analysed (L). The expression levels of PARP, cleaved PARP and LAMA4 in tumours were measured by Western blot (M). Data in D, F, H, J, L were analysed by Student’s t test, *p < 0.05, **p < 0.01, ***p < 0.001 Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36539799), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Laminin alpha 4 by Western Blot

Detection of Laminin alpha 4 by Western Blot

KLF4 upregulates LAMA4 expression. A-B Heatmap showing the altered genes identified by RNA sequencing analysis in LINC00629 (A)- or KLF4 (B)-depleted MNNG/HOS cells. C Volcano plots showing differentially expressed mRNAs for LINC00629 knockdown or KLF4 knockdown versus the controls (absolute log2-fold change > 1 and q value < 0.05). The green dot indicates the downregulated genes, and the red dot indicates the upregulated genes. D The mRNA levels of LAMA4 are shown from RNA sequencing data. E-F The protein and mRNA levels of LAMA4 were detected by Western blot (E) and qRT–PCR (F) in MNNG/HOS cells with or without LINC00629 or KLF4 knockdown. Numbers represent the relative intensities of western blot bands of LAMA4 to GAPDH. G MNNG/HOS cells with or without KLF4 or LINC00629 knockdown were treated with 3 μM TM for 36 h. The expression of LAMA4 was detected by Western blot. Numbers represent the relative intensities of western blot bands of LAMA4 to GAPDH. H-I LINC00629 was overexpressed in MNNG/HOS cells with or without KLF4 knockdown. The protein and mRNA levels of LAMA4 were detected by Western blotting (H) and qRT–PCR (I). Numbers represent the relative intensities of western blot bands of LAMA4 to GAPDH. Data in F and M were analysed by Student’s t test, *p < 0.05, **p < 0.01, ***p < 0.001 Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36539799), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Laminin alpha 4 by Western Blot

Detection of Laminin alpha 4 by Western Blot

Knockdown of LAMA4 suppresses the malignant behaviour of osteosarcoma and accelerates ER stress-induced apoptosis. A The expression levels of LAMA4 in osteosarcoma (n = 88) and normal tissues (n = 564) were analysed from the TNMplot database. B LAMA4 was knocked down in MNNG/HOS and 143B cells. The expression of LAMA4 was detected by Western blot. GAPDH was used as the loading control. C-D The cells (3000 cells/well) with or without LAMA4 depletion were tested for cell growth in the colony formation assay. Viable colonies after 1 week were counted and are shown (C). Data are depicted as bar graphs (D). E-F The migration of the indicated cells was detected by Transwell assays. Representative images of crystal violet-stained culture plates are shown (E). Data are depicted as bar graphs (F). G-H MNNG/HOS cells with or without LAMA4 knockdown were treated with 3 μM TM for 36 h. Cell apoptosis and cell viability were analysed by Western blot (G) and CCK8 assays (H). GAPDH was used as the loading control. I-J MNNG/HOS cells with or without LAMA4 knockdown were treated with 1 μM TG for 36 h. Cell apoptosis and cell viability were analysed by Western blot (I) and CCK8 assays (J). GAPDH was used as the loading control. K-M MNNG/HOS cells (106 cells per mouse) with or without LAMA4 knockdown were injected subcutaneously into nude mice (n = 4). Representative images of xenograft tumours (K). The weights of the tumours were calculated and analysed (L). The expression levels of PARP, cleaved PARP and LAMA4 in tumours were measured by Western blot (M). Data in D, F, H, J, L were analysed by Student’s t test, *p < 0.05, **p < 0.01, ***p < 0.001 Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36539799), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Laminin alpha 4 by Western Blot

Detection of Laminin alpha 4 by Western Blot

Knockdown of LAMA4 suppresses the malignant behaviour of osteosarcoma and accelerates ER stress-induced apoptosis. A The expression levels of LAMA4 in osteosarcoma (n = 88) and normal tissues (n = 564) were analysed from the TNMplot database. B LAMA4 was knocked down in MNNG/HOS and 143B cells. The expression of LAMA4 was detected by Western blot. GAPDH was used as the loading control. C-D The cells (3000 cells/well) with or without LAMA4 depletion were tested for cell growth in the colony formation assay. Viable colonies after 1 week were counted and are shown (C). Data are depicted as bar graphs (D). E-F The migration of the indicated cells was detected by Transwell assays. Representative images of crystal violet-stained culture plates are shown (E). Data are depicted as bar graphs (F). G-H MNNG/HOS cells with or without LAMA4 knockdown were treated with 3 μM TM for 36 h. Cell apoptosis and cell viability were analysed by Western blot (G) and CCK8 assays (H). GAPDH was used as the loading control. I-J MNNG/HOS cells with or without LAMA4 knockdown were treated with 1 μM TG for 36 h. Cell apoptosis and cell viability were analysed by Western blot (I) and CCK8 assays (J). GAPDH was used as the loading control. K-M MNNG/HOS cells (106 cells per mouse) with or without LAMA4 knockdown were injected subcutaneously into nude mice (n = 4). Representative images of xenograft tumours (K). The weights of the tumours were calculated and analysed (L). The expression levels of PARP, cleaved PARP and LAMA4 in tumours were measured by Western blot (M). Data in D, F, H, J, L were analysed by Student’s t test, *p < 0.05, **p < 0.01, ***p < 0.001 Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36539799), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Laminin alpha 4 by Western Blot

Detection of Laminin alpha 4 by Western Blot

KLF4 upregulates LAMA4 expression. A-B Heatmap showing the altered genes identified by RNA sequencing analysis in LINC00629 (A)- or KLF4 (B)-depleted MNNG/HOS cells. C Volcano plots showing differentially expressed mRNAs for LINC00629 knockdown or KLF4 knockdown versus the controls (absolute log2-fold change > 1 and q value < 0.05). The green dot indicates the downregulated genes, and the red dot indicates the upregulated genes. D The mRNA levels of LAMA4 are shown from RNA sequencing data. E-F The protein and mRNA levels of LAMA4 were detected by Western blot (E) and qRT–PCR (F) in MNNG/HOS cells with or without LINC00629 or KLF4 knockdown. Numbers represent the relative intensities of western blot bands of LAMA4 to GAPDH. G MNNG/HOS cells with or without KLF4 or LINC00629 knockdown were treated with 3 μM TM for 36 h. The expression of LAMA4 was detected by Western blot. Numbers represent the relative intensities of western blot bands of LAMA4 to GAPDH. H-I LINC00629 was overexpressed in MNNG/HOS cells with or without KLF4 knockdown. The protein and mRNA levels of LAMA4 were detected by Western blotting (H) and qRT–PCR (I). Numbers represent the relative intensities of western blot bands of LAMA4 to GAPDH. Data in F and M were analysed by Student’s t test, *p < 0.05, **p < 0.01, ***p < 0.001 Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36539799), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Laminin alpha 4 by Western Blot

Detection of Laminin alpha 4 by Western Blot

Knockdown of LAMA4 suppresses the malignant behaviour of osteosarcoma and accelerates ER stress-induced apoptosis. A The expression levels of LAMA4 in osteosarcoma (n = 88) and normal tissues (n = 564) were analysed from the TNMplot database. B LAMA4 was knocked down in MNNG/HOS and 143B cells. The expression of LAMA4 was detected by Western blot. GAPDH was used as the loading control. C-D The cells (3000 cells/well) with or without LAMA4 depletion were tested for cell growth in the colony formation assay. Viable colonies after 1 week were counted and are shown (C). Data are depicted as bar graphs (D). E-F The migration of the indicated cells was detected by Transwell assays. Representative images of crystal violet-stained culture plates are shown (E). Data are depicted as bar graphs (F). G-H MNNG/HOS cells with or without LAMA4 knockdown were treated with 3 μM TM for 36 h. Cell apoptosis and cell viability were analysed by Western blot (G) and CCK8 assays (H). GAPDH was used as the loading control. I-J MNNG/HOS cells with or without LAMA4 knockdown were treated with 1 μM TG for 36 h. Cell apoptosis and cell viability were analysed by Western blot (I) and CCK8 assays (J). GAPDH was used as the loading control. K-M MNNG/HOS cells (106 cells per mouse) with or without LAMA4 knockdown were injected subcutaneously into nude mice (n = 4). Representative images of xenograft tumours (K). The weights of the tumours were calculated and analysed (L). The expression levels of PARP, cleaved PARP and LAMA4 in tumours were measured by Western blot (M). Data in D, F, H, J, L were analysed by Student’s t test, *p < 0.05, **p < 0.01, ***p < 0.001 Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36539799), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Laminin alpha 4 by Western Blot

Detection of Laminin alpha 4 by Western Blot

Knockdown of LAMA4 suppresses the malignant behaviour of osteosarcoma and accelerates ER stress-induced apoptosis. A The expression levels of LAMA4 in osteosarcoma (n = 88) and normal tissues (n = 564) were analysed from the TNMplot database. B LAMA4 was knocked down in MNNG/HOS and 143B cells. The expression of LAMA4 was detected by Western blot. GAPDH was used as the loading control. C-D The cells (3000 cells/well) with or without LAMA4 depletion were tested for cell growth in the colony formation assay. Viable colonies after 1 week were counted and are shown (C). Data are depicted as bar graphs (D). E-F The migration of the indicated cells was detected by Transwell assays. Representative images of crystal violet-stained culture plates are shown (E). Data are depicted as bar graphs (F). G-H MNNG/HOS cells with or without LAMA4 knockdown were treated with 3 μM TM for 36 h. Cell apoptosis and cell viability were analysed by Western blot (G) and CCK8 assays (H). GAPDH was used as the loading control. I-J MNNG/HOS cells with or without LAMA4 knockdown were treated with 1 μM TG for 36 h. Cell apoptosis and cell viability were analysed by Western blot (I) and CCK8 assays (J). GAPDH was used as the loading control. K-M MNNG/HOS cells (106 cells per mouse) with or without LAMA4 knockdown were injected subcutaneously into nude mice (n = 4). Representative images of xenograft tumours (K). The weights of the tumours were calculated and analysed (L). The expression levels of PARP, cleaved PARP and LAMA4 in tumours were measured by Western blot (M). Data in D, F, H, J, L were analysed by Student’s t test, *p < 0.05, **p < 0.01, ***p < 0.001 Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36539799), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Laminin alpha 4 by Immunohistochemistry

Detection of Laminin alpha 4 by Immunohistochemistry

Knockdown of LAMA4 suppresses the malignant behaviour of osteosarcoma and accelerates ER stress-induced apoptosis. A The expression levels of LAMA4 in osteosarcoma (n = 88) and normal tissues (n = 564) were analysed from the TNMplot database. B LAMA4 was knocked down in MNNG/HOS and 143B cells. The expression of LAMA4 was detected by Western blot. GAPDH was used as the loading control. C-D The cells (3000 cells/well) with or without LAMA4 depletion were tested for cell growth in the colony formation assay. Viable colonies after 1 week were counted and are shown (C). Data are depicted as bar graphs (D). E-F The migration of the indicated cells was detected by Transwell assays. Representative images of crystal violet-stained culture plates are shown (E). Data are depicted as bar graphs (F). G-H MNNG/HOS cells with or without LAMA4 knockdown were treated with 3 μM TM for 36 h. Cell apoptosis and cell viability were analysed by Western blot (G) and CCK8 assays (H). GAPDH was used as the loading control. I-J MNNG/HOS cells with or without LAMA4 knockdown were treated with 1 μM TG for 36 h. Cell apoptosis and cell viability were analysed by Western blot (I) and CCK8 assays (J). GAPDH was used as the loading control. K-M MNNG/HOS cells (106 cells per mouse) with or without LAMA4 knockdown were injected subcutaneously into nude mice (n = 4). Representative images of xenograft tumours (K). The weights of the tumours were calculated and analysed (L). The expression levels of PARP, cleaved PARP and LAMA4 in tumours were measured by Western blot (M). Data in D, F, H, J, L were analysed by Student’s t test, *p < 0.05, **p < 0.01, ***p < 0.001 Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36539799), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Laminin alpha 4 by Western Blot

Detection of Laminin alpha 4 by Western Blot

Knockdown of LAMA4 suppresses the malignant behaviour of osteosarcoma and accelerates ER stress-induced apoptosis. A The expression levels of LAMA4 in osteosarcoma (n = 88) and normal tissues (n = 564) were analysed from the TNMplot database. B LAMA4 was knocked down in MNNG/HOS and 143B cells. The expression of LAMA4 was detected by Western blot. GAPDH was used as the loading control. C-D The cells (3000 cells/well) with or without LAMA4 depletion were tested for cell growth in the colony formation assay. Viable colonies after 1 week were counted and are shown (C). Data are depicted as bar graphs (D). E-F The migration of the indicated cells was detected by Transwell assays. Representative images of crystal violet-stained culture plates are shown (E). Data are depicted as bar graphs (F). G-H MNNG/HOS cells with or without LAMA4 knockdown were treated with 3 μM TM for 36 h. Cell apoptosis and cell viability were analysed by Western blot (G) and CCK8 assays (H). GAPDH was used as the loading control. I-J MNNG/HOS cells with or without LAMA4 knockdown were treated with 1 μM TG for 36 h. Cell apoptosis and cell viability were analysed by Western blot (I) and CCK8 assays (J). GAPDH was used as the loading control. K-M MNNG/HOS cells (106 cells per mouse) with or without LAMA4 knockdown were injected subcutaneously into nude mice (n = 4). Representative images of xenograft tumours (K). The weights of the tumours were calculated and analysed (L). The expression levels of PARP, cleaved PARP and LAMA4 in tumours were measured by Western blot (M). Data in D, F, H, J, L were analysed by Student’s t test, *p < 0.05, **p < 0.01, ***p < 0.001 Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36539799), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Laminin alpha 4 by Immunohistochemistry

Detection of Laminin alpha 4 by Immunohistochemistry

Knockdown of LAMA4 suppresses the malignant behaviour of osteosarcoma and accelerates ER stress-induced apoptosis. A The expression levels of LAMA4 in osteosarcoma (n = 88) and normal tissues (n = 564) were analysed from the TNMplot database. B LAMA4 was knocked down in MNNG/HOS and 143B cells. The expression of LAMA4 was detected by Western blot. GAPDH was used as the loading control. C-D The cells (3000 cells/well) with or without LAMA4 depletion were tested for cell growth in the colony formation assay. Viable colonies after 1 week were counted and are shown (C). Data are depicted as bar graphs (D). E-F The migration of the indicated cells was detected by Transwell assays. Representative images of crystal violet-stained culture plates are shown (E). Data are depicted as bar graphs (F). G-H MNNG/HOS cells with or without LAMA4 knockdown were treated with 3 μM TM for 36 h. Cell apoptosis and cell viability were analysed by Western blot (G) and CCK8 assays (H). GAPDH was used as the loading control. I-J MNNG/HOS cells with or without LAMA4 knockdown were treated with 1 μM TG for 36 h. Cell apoptosis and cell viability were analysed by Western blot (I) and CCK8 assays (J). GAPDH was used as the loading control. K-M MNNG/HOS cells (106 cells per mouse) with or without LAMA4 knockdown were injected subcutaneously into nude mice (n = 4). Representative images of xenograft tumours (K). The weights of the tumours were calculated and analysed (L). The expression levels of PARP, cleaved PARP and LAMA4 in tumours were measured by Western blot (M). Data in D, F, H, J, L were analysed by Student’s t test, *p < 0.05, **p < 0.01, ***p < 0.001 Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36539799), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Laminin alpha 4 by Western Blot

Detection of Laminin alpha 4 by Western Blot

KLF4 upregulates LAMA4 expression. A-B Heatmap showing the altered genes identified by RNA sequencing analysis in LINC00629 (A)- or KLF4 (B)-depleted MNNG/HOS cells. C Volcano plots showing differentially expressed mRNAs for LINC00629 knockdown or KLF4 knockdown versus the controls (absolute log2-fold change > 1 and q value < 0.05). The green dot indicates the downregulated genes, and the red dot indicates the upregulated genes. D The mRNA levels of LAMA4 are shown from RNA sequencing data. E-F The protein and mRNA levels of LAMA4 were detected by Western blot (E) and qRT–PCR (F) in MNNG/HOS cells with or without LINC00629 or KLF4 knockdown. Numbers represent the relative intensities of western blot bands of LAMA4 to GAPDH. G MNNG/HOS cells with or without KLF4 or LINC00629 knockdown were treated with 3 μM TM for 36 h. The expression of LAMA4 was detected by Western blot. Numbers represent the relative intensities of western blot bands of LAMA4 to GAPDH. H-I LINC00629 was overexpressed in MNNG/HOS cells with or without KLF4 knockdown. The protein and mRNA levels of LAMA4 were detected by Western blotting (H) and qRT–PCR (I). Numbers represent the relative intensities of western blot bands of LAMA4 to GAPDH. Data in F and M were analysed by Student’s t test, *p < 0.05, **p < 0.01, ***p < 0.001 Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36539799), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Laminin alpha 4 by Western Blot

Detection of Laminin alpha 4 by Western Blot

KLF4 upregulates LAMA4 expression. A-B Heatmap showing the altered genes identified by RNA sequencing analysis in LINC00629 (A)- or KLF4 (B)-depleted MNNG/HOS cells. C Volcano plots showing differentially expressed mRNAs for LINC00629 knockdown or KLF4 knockdown versus the controls (absolute log2-fold change > 1 and q value < 0.05). The green dot indicates the downregulated genes, and the red dot indicates the upregulated genes. D The mRNA levels of LAMA4 are shown from RNA sequencing data. E-F The protein and mRNA levels of LAMA4 were detected by Western blot (E) and qRT–PCR (F) in MNNG/HOS cells with or without LINC00629 or KLF4 knockdown. Numbers represent the relative intensities of western blot bands of LAMA4 to GAPDH. G MNNG/HOS cells with or without KLF4 or LINC00629 knockdown were treated with 3 μM TM for 36 h. The expression of LAMA4 was detected by Western blot. Numbers represent the relative intensities of western blot bands of LAMA4 to GAPDH. H-I LINC00629 was overexpressed in MNNG/HOS cells with or without KLF4 knockdown. The protein and mRNA levels of LAMA4 were detected by Western blotting (H) and qRT–PCR (I). Numbers represent the relative intensities of western blot bands of LAMA4 to GAPDH. Data in F and M were analysed by Student’s t test, *p < 0.05, **p < 0.01, ***p < 0.001 Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36539799), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Laminin alpha 4 by Western Blot

Detection of Laminin alpha 4 by Western Blot

Knockdown of LAMA4 suppresses the malignant behaviour of osteosarcoma and accelerates ER stress-induced apoptosis. A The expression levels of LAMA4 in osteosarcoma (n = 88) and normal tissues (n = 564) were analysed from the TNMplot database. B LAMA4 was knocked down in MNNG/HOS and 143B cells. The expression of LAMA4 was detected by Western blot. GAPDH was used as the loading control. C-D The cells (3000 cells/well) with or without LAMA4 depletion were tested for cell growth in the colony formation assay. Viable colonies after 1 week were counted and are shown (C). Data are depicted as bar graphs (D). E-F The migration of the indicated cells was detected by Transwell assays. Representative images of crystal violet-stained culture plates are shown (E). Data are depicted as bar graphs (F). G-H MNNG/HOS cells with or without LAMA4 knockdown were treated with 3 μM TM for 36 h. Cell apoptosis and cell viability were analysed by Western blot (G) and CCK8 assays (H). GAPDH was used as the loading control. I-J MNNG/HOS cells with or without LAMA4 knockdown were treated with 1 μM TG for 36 h. Cell apoptosis and cell viability were analysed by Western blot (I) and CCK8 assays (J). GAPDH was used as the loading control. K-M MNNG/HOS cells (106 cells per mouse) with or without LAMA4 knockdown were injected subcutaneously into nude mice (n = 4). Representative images of xenograft tumours (K). The weights of the tumours were calculated and analysed (L). The expression levels of PARP, cleaved PARP and LAMA4 in tumours were measured by Western blot (M). Data in D, F, H, J, L were analysed by Student’s t test, *p < 0.05, **p < 0.01, ***p < 0.001 Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36539799), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Laminin alpha 4 by Western Blot

Detection of Laminin alpha 4 by Western Blot

KLF4 upregulates LAMA4 expression. A-B Heatmap showing the altered genes identified by RNA sequencing analysis in LINC00629 (A)- or KLF4 (B)-depleted MNNG/HOS cells. C Volcano plots showing differentially expressed mRNAs for LINC00629 knockdown or KLF4 knockdown versus the controls (absolute log2-fold change > 1 and q value < 0.05). The green dot indicates the downregulated genes, and the red dot indicates the upregulated genes. D The mRNA levels of LAMA4 are shown from RNA sequencing data. E-F The protein and mRNA levels of LAMA4 were detected by Western blot (E) and qRT–PCR (F) in MNNG/HOS cells with or without LINC00629 or KLF4 knockdown. Numbers represent the relative intensities of western blot bands of LAMA4 to GAPDH. G MNNG/HOS cells with or without KLF4 or LINC00629 knockdown were treated with 3 μM TM for 36 h. The expression of LAMA4 was detected by Western blot. Numbers represent the relative intensities of western blot bands of LAMA4 to GAPDH. H-I LINC00629 was overexpressed in MNNG/HOS cells with or without KLF4 knockdown. The protein and mRNA levels of LAMA4 were detected by Western blotting (H) and qRT–PCR (I). Numbers represent the relative intensities of western blot bands of LAMA4 to GAPDH. Data in F and M were analysed by Student’s t test, *p < 0.05, **p < 0.01, ***p < 0.001 Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36539799), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Laminin alpha 4 by Western Blot

Detection of Laminin alpha 4 by Western Blot

KLF4 upregulates LAMA4 expression. A-B Heatmap showing the altered genes identified by RNA sequencing analysis in LINC00629 (A)- or KLF4 (B)-depleted MNNG/HOS cells. C Volcano plots showing differentially expressed mRNAs for LINC00629 knockdown or KLF4 knockdown versus the controls (absolute log2-fold change > 1 and q value < 0.05). The green dot indicates the downregulated genes, and the red dot indicates the upregulated genes. D The mRNA levels of LAMA4 are shown from RNA sequencing data. E-F The protein and mRNA levels of LAMA4 were detected by Western blot (E) and qRT–PCR (F) in MNNG/HOS cells with or without LINC00629 or KLF4 knockdown. Numbers represent the relative intensities of western blot bands of LAMA4 to GAPDH. G MNNG/HOS cells with or without KLF4 or LINC00629 knockdown were treated with 3 μM TM for 36 h. The expression of LAMA4 was detected by Western blot. Numbers represent the relative intensities of western blot bands of LAMA4 to GAPDH. H-I LINC00629 was overexpressed in MNNG/HOS cells with or without KLF4 knockdown. The protein and mRNA levels of LAMA4 were detected by Western blotting (H) and qRT–PCR (I). Numbers represent the relative intensities of western blot bands of LAMA4 to GAPDH. Data in F and M were analysed by Student’s t test, *p < 0.05, **p < 0.01, ***p < 0.001 Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36539799), licensed under a CC-BY license. Not internally tested by R&D Systems.

Applications for Human Laminin  alpha 4 Antibody

Application
Recommended Usage

Immunocytochemistry

5-15 µg/mL
Sample: Immersion fixed T98G human glioblastoma cell line induced with EMT

Immunohistochemistry

3-25 µg/mL
Sample: Immersion fixed paraffin-embedded sections of human placenta

Simple Western

20 µg/mL
Sample: Human placenta tissue

Western Blot

2 µg/mL
Sample: Human placenta tissue

Neutralization

Measured by its ability to neutralize Laminin  alpha 4-induced adhesion in the HT1080 human fibrosarcoma cell line. The Neutralization Dose (ND50) is typically 1.5-7.5 µg/mL in the presence of 5 µg/mL Recombinant Human Laminin  alpha 4.

Formulation, Preparation, and Storage

Purification

Antigen Affinity-purified

Reconstitution

Sterile PBS to a final concentration of 0.2 mg/mL. For liquid material, refer to CoA for concentration.


Loading...

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Calculators

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: Laminin alpha 4

Laminin alpha 4 (LAMA-4 [Laminin subunit alpha 4]; also Laminin-14/423, -8/411 and -9/421 subunit alpha) is a 180-230 kDa secreted member of the laminin family of molecules. It is found in the basement membranes of adipocytes, endothelial cells, cardiac and visceral smooth muscle cells, fibroblasts, keratinocytes, and pancreatic acinar cells. Laminin is a heterotrimeric glycoprotein that attaches cells to basement membranes. It is composed of covalently-linked alpha -, beta - and gamma -chains, and is known to attach cells to basement membranes. In the case of the alpha -subunit, this is mediated through binding to multiple integrins ( alpha 3 beta 1, alpha v beta 3 and alpha 6 beta 1), plus dystroglycan and the syndecans-2 and -4. Mature human Laminin alpha 4 is 1799 amino acids (aa) in length (aa 25-1823). It contains multiple domains, including four EGF‑like domains (aa 82-255) and five Laminin G-like domains (aa 833-1820). There is a chondroitin sulfate attachment at the N‑terminus that accounts for 20-30 kDa of MW. Laminin alpha 4 is cleaved between the Laminin G-like 3 and 4 domains, creating a soluble 44 kDa fragment that possesses antibacterial activity. There are two potential splice variants, one that shows a deletion of aa 266-272, and another that contains a 55 aa substitution for aa 66-1823. Over aa 826-1816, human Laminin alpha 4 shares 91% aa sequence identity with mouse Laminin alpha 4.

Alternate Names

LAMA4

Entrez Gene IDs

3910 (Human); 16775 (Mouse); 309816 (Rat)

Gene Symbol

LAMA4

UniProt

Additional Laminin alpha 4 Products

Product Documents for Human Laminin  alpha 4 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Human Laminin  alpha 4 Antibody

For research use only

Related Research Areas

Citations for Human Laminin  alpha 4 Antibody

Customer Reviews for Human Laminin  alpha 4 Antibody

There are currently no reviews for this product. Be the first to review Human Laminin  alpha 4 Antibody and earn rewards!

Have you used Human Laminin  alpha 4 Antibody?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs

No product specific FAQs exist for this product.

View all FAQs for Antibodies